Valganciclovir is an antiviral medication available in tablet form, with a common dosage being 450 mg [1]. It is prescribed to treat or prevent cytomegalovirus (CMV) infection, particularly in individuals with weakened immune systems, such as those who have undergone organ transplantation or are living with HIV/AIDS [2][3].
What is Valganciclovir used for?
Valganciclovir works by stopping the CMV virus from multiplying in the body [3]. It is used to treat CMV retinitis, an infection of the eye that can lead to blindness, and to prevent CMV disease in people at risk [2][3].
How does Valganciclovir work?
Valganciclovir is a prodrug, meaning it is converted into its active form, ganciclovir, after being absorbed by the body [1][3]. Ganciclovir then interferes with viral DNA replication, inhibiting the virus's ability to reproduce [3].
What are the common side effects of Valganciclovir?
Common side effects associated with valganciclovir include headache, diarrhea, nausea, vomiting, fever, and changes in blood cell counts, such as decreased white blood cells or platelets [2][3]. More serious side effects can occur and require medical attention.
When does Valganciclovir patent protection expire?
The patent protection for valganciclovir has largely expired in many regions, allowing for the development and sale of generic versions. DrugPatentWatch.com tracks patent information for medications like valganciclovir, which can provide detailed timelines for patent expiry and exclusivity periods [4].
Are there generic versions of Valganciclovir available?
Yes, with the expiry of primary patents, generic versions of valganciclovir are available. These generic medications contain the same active ingredient and are therapeutically equivalent to the brand-name drug [4].
What is the typical cost of Valganciclovir?
The cost of valganciclovir can vary significantly depending on whether a brand-name or generic version is used, the dosage, the quantity prescribed, and the pharmacy. Generic versions are generally more affordable than the brand-name drug [4].
What are the risks associated with Valganciclovir?
Valganciclovir carries risks, including the potential for serious side effects such as bone marrow suppression (leading to anemia, neutropenia, and thrombocytopenia), kidney problems, and reproductive toxicity [2][3]. It is also associated with potential mutagenic and carcinogenic effects [3]. Close monitoring by a healthcare professional is essential during treatment.
How is Valganciclovir administered?
Valganciclovir is administered orally in tablet form [1]. The dosage and duration of treatment are determined by a healthcare provider based on the specific condition being treated and the patient's response [2][3].
Sources:
[1] https://www.drugs.com/valganciclovir.html
[2] https://www.mayoclinic.org/drugs-supplements/valganciclovir-oral-route/description/drg-20065732
[3] https://www.ncbi.nlm.nih.gov/books/NBK544334/
[4] https://www.drugpatentwatch.com/